BiotechTube

Budesonide Foam

Phase 3Terminated
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Proctitis

Conditions

Proctitis, Proctosigmoiditis

Trial Timeline

May 31, 2011 → Dec 31, 2014

NCT ID
NCT01349673

About Budesonide Foam

Budesonide Foam is a phase 3 stage product being developed by Bausch Health for Proctitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01349673. Target conditions include Proctitis, Proctosigmoiditis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01349673Phase 3Terminated

Competing Products

3 competing products in Proctitis

See all competitors
ProductCompanyStageHype Score
Mesalamine + Canasa + PlaceboSandoz GroupPhase 3
74
Budesonide + PlaceboBausch HealthPhase 3
72
Budesonide + PlaceboBausch HealthPhase 3
72

Other Products from Bausch Health

nabiloneApproved
80
High dose budesonide rectal foam + Low dose budesonide rectal foam + Matching placebo rectal foamApproved
80
benzoyl peroxide wash + Tretinoin gelApproved
80
Adapalene Gel + Tretinoin GelApproved
80
Omeprazole/sodium bicarbonateApproved
80